Article Details

Roche's Polivy to hit $2.4B as doctors expect 'significant switching' in newly diagnosed ...

Retrieved on: 2021-09-07 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Roche's Polivy to hit $2.4B as doctors expect 'significant switching' in newly diagnosed .... View article details on hiswai:

Excerpt

Roche Pharmaceuticals CEO Bill Anderson recently pegged lymphoma drug Polivy's potential expansion into newly diagnosed patients as a multibillion-dollar ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up